‘We have to be able to show a return on investment’
CHICAGO – Health plans, hospitals and employers depend on technology like wearable devices to better understand, evaluate and manage the health of their populations. Lori Herb, senior director of clinical outreach and engagement at health care analytic solutions and services company Geneia, talked with us about the role of wearable devices in remote patient monitoring programs.
HHTN: What role do wearable devices play in health care management?
HERB: Wearables allow for the use of biometric data to be incorporated into existing case and disease management programs to better manage the health of the members participating in these programs. These patients are the highest risk and having this data allows for improved outcomes by reducing cost, and improving quality and program satisfaction.
HHTN: What are some obstacles to broader reimbursement of these devices?
HERB: We have to be able to show a return on investment as we expand out to additional disease states. Using analytics to identify members who would benefit from home monitoring is key to improving outcomes and seeing a return on investment.
HHTN: Do you think we will see broader reimbursement in the future?
HERB: If there continues to be positive outcomes with the use of devices, there will be greater consideration for reimbursement. We need to continue to see improvements in the risk of the population, resulting in lower costs and improved outcomes.
HHTN: Why is this a technology that’s worth reimbursing?
HERB: Technology allows for better use of clinical resources by providing the ability to intervene in a patient’s care when needed, sometimes without even needing to make a visit to the home.